期刊文献+

重组腺病毒Ad-PD-L1转染供体小鼠树突状细胞对受体小鼠淋巴细胞激活的影响

Effect of recombinant adenovirus Ad-PD-L1 transfection of donor mouse dendritic cells on the activation of receptor mouse lymphocytes
下载PDF
导出
摘要 目的:观察重组腺病毒载体Ad-PD-L1转染供体C57BL/6(H-2b)小鼠树突状细胞(DC)对受体DBA/2(H-2d)小鼠淋巴细胞增殖和激活的影响.方法:构建腺病毒穿梭质粒pShuttle-GFP-CMV(-)-PD-L1和腺病毒骨架质粒pAdxsi-GFP-CMV-PD-L1,对重组腺病毒Ad-PD-L1进行包装、扩增和纯化.分离培养供体C57BL/6小鼠的DC,分为3组:腺病毒载体Ad-PD-L1转染组(A组),空载体转染组(B组)和对照组(C组).Western blot检测转染后各组细胞PD-L1的表达.分离受体DBA/2小鼠的淋巴细胞,用羧基荧光素二醋酸琥珀酰亚胺酯(CFSE)标记,将供体C57BL/6小鼠的DC和受体DBA/2小鼠淋巴细胞混合培养,流式细胞仪观察淋巴细胞的增殖情况.结果:酶切及测序证实含PD-L1的重组腺病毒载体Ad-PD-L1构建成功.转染供体C57BL/6小鼠的DC后其PD-L1的表达升高37%(P<0.05),将转染了PD-L1的DC与受体DBA/2小鼠的淋巴细胞进行共培养.与对照组相比,PD-L1表达升高后,明显地抑制了淋巴细胞的增殖和活化.受体DBA/2小鼠的淋巴细胞增殖降低41%(P<0.01).结论:转染供体C57BL/6小鼠DC后通过共刺激通路PD-1/PD-L1抑制了受体DBA/2小鼠淋巴细胞的增殖和激活. AIM: To investigate the effect of recombinant adenovirus Ad-PD-L1 transfection of donor mouse C57BL/6 (H-2^b) dendritic cells on the activation of receptor mouse DBA/2(H-2^d) lymphocytes. METHODS: pShuttle-GFP-CMV(-) plasmid and adenovirus bone plasmid pAdxsi-GFP-CMV- PD-L1 were constructed. The recombinant adenovirus Ad-PD-L1 was packed, amplied and purified. Dendritic cells derived from donor mouse C57BL/6 bone marrow were isolated and cultured. The cells ware divided into 3 groups. Group A and Group B were transfected with recombinant adenovirus Ad-PD-L1-GFP and Ad-GFP respectively, and Group C served as blank control group. The expression of PD-L1 was monitored by GFP fluorescence in the infected cells and identified by Western blot. The lymphocytes of receptor mouse DBA/2 were isolated, and then labeled by carboxyfluorescein succinimidylester (CFSE). After co-cultured with the dendritic cells in the three groups, flow cytometry was used to observe the proliferation and activation of lymphocytes from DBA/2 mice. RESULTS: Enzyme digestion and sequencing confirmed the successful construction of recombinant adenovirus Ad-PD-L1. After transfection with Ad-PD-L1, PD-L1 expression of dendritic cells was verified by Western blot. The expres- sion of PD-L1 in the dendritic cells infected with Ad-PD-L1 was increased by 37% (P 〈 0.05). After co-cultured with the lymphocytes from DBA/2 mice, the proliferation and activation of receptor lymphocytes were suppressed remarkably, and the proliferation rate was decreased by 41% as compared with that in the control group. CONCLUSION: Transfection of donor mouse dendritic cells with recombinant adenovirus suppresses the proliferation and activation of lymphocytes from receptor mice through PD-1/ PD-L1 co-stimulatory pathway.
出处 《世界华人消化杂志》 CAS 北大核心 2008年第17期1859-1865,共7页 World Chinese Journal of Digestology
基金 国家自然科学基金资助项目 No.30471637~~
关键词 PD-L1 PD-1 共刺激通路 腺病毒载体 树突状细胞 淋巴细胞激活 Programmed death-1 Programmed death ligand-1 Adenovirus vector Dendritic cell Activation of lymphocyte
  • 相关文献

参考文献23

  • 1Nurieva R, Thomas S, Nguyen T, Martin-Orozco N, Wang Y, Kaja MK, Yu XZ, Dong C. T-cell tolerance or function is determined by combinatorial costimulatory signals. EMBO J 2006; 25:2623-2633.
  • 2Collins M, Ling V, Carreno BM. The B7 family of immune-regulatory ligands. Genome Biol 2005; 6: 223.
  • 3Snanoudj R, de Preneuf H, Creput C, Arzouk N, Deroure B, Beaudreuil S, Durrbach A, Charpentier B. Costimulation blockade and its possible future use in clinical transplantation. Transpl Int 2006; 19: 693-704.
  • 4Koga N, Suzuki J, Kosuge H, Haraguchi G, Onai Y, Futamatsu H, Maejima Y, Gotoh R, Saiki H, Tsushima F, Azuma M, lsobe M. Blockade of the interaction between PD-1 and PD-L1 accelerates graft arterial disease in cardiac allografts. Arterioscler Thromb Vasc Biol 2004; 24:2057-2062.
  • 5Cai G, Karni A, Oliveira EM, Weiner HL, Hafler DA, Freeman GJ. PD-1 ligands, negative regulators for activation of naive, memory, and recently activated human CD4+ T cells. Cell Immunol 2004;230:89-98.
  • 6Konishi J, Yamazaki K, Azuma M, Kinoshita I, Dosaka-Akita H, Nishimura M. B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression. Clin Cancer Res 2004; 10: 5094-5100.
  • 7Iwai Y, Terawaki S, Ikegawa M, Okazaki T, Honjo T. PD-1 inhibits antiviral immunity at the effector phase in the liver. J Exp Med 2003; 198:39-50.
  • 8Liang SC, Latchman YE, Buhlmann JE, Tomczak MF, Horwitz BH, Freeman GJ, Sharpe AH. Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur J Immunol 2003; 33:2706-2716.
  • 9Latchman YE, Liang SC, Wu Y, Chernova T, Sobel RA, Klemm M, Kuchroo VK, Freeman GJ, Sharpe AH. PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. Proc Natl Acad Sci U S A 2004; 101:10691-10696.
  • 10Schreiner B, Mitsdoerffer M, Kieseier BC, Chen L, Hartung HP, Weller M, Wiendl H. Interferon- beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis. J Neuroimmunol 2004; 155:172-182.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部